... Kyle Mcnally
Read More DNA and RNA Purity Ratios: A260/A280 and A260/A230 Explained

... Kyle Mcnally by / 09.01.2026
Read More DNA and RNA Purity Ratios: A260/A280 and A260/A230 Explained
Frequently Asked Questions... Kyle Mcnally by / 08.25.2026
Read More Building a Better Sample QC Workflow: From Extraction to Sequencing
The chemistry of your qPCR supermix can influence analytical... Emily Payne, PhD by / 08.21.2026
Read More Think your supermix is good enough? Prove it.
The promise of precision oncology rests on our ability to re... Deepak Tripathi, PhD by / 08.18.2026
Read More A scalable multiplex miRNA profiling workflow for precision oncology research
Sanger sequencing has long been the gold standard for accura... by Behind The Bench Staff / 08.05.2026
Read More Advancing the Gold Standard: Faster, Smarter, and Built for Challenging Templates
Chimeric antigen receptor (CAR)-T cell therapies represent a... by Behind The Bench Staff / 07.28.2026
Read More Managing Formulation, Fill & Finish in the CAR T-Cell Manufacturing Process
What is epigenetics and why does it matter? What are you stu... Jordan Ruggieri, MBA by / 05.28.2026
Read More Epigenetics unlocked: How behavior shapes biology
Chimeric Antigen Receptor (CAR) T cell therapy has transform... by Behind The Bench Staff / 05.16.2026
Read More Allogeneic cell therapies: Enhancing patient access via off-the-shelf options

Can You Perform SNP Genotyping Without DNA Purification? The... Emily Payne, PhD by / 04.06.2026
Read More Direct-from-Lysate SNP Genotyping in Research Applications